{"title":"Interstitial cystitis—an imbalance of risk and protective factors?","authors":"J. Westropp, Judi L. Stella, C. Buffington","doi":"10.3389/fpain.2024.1405488","DOIUrl":null,"url":null,"abstract":"Interstitial cystitis (IC) presents as a chronic pain condition with variable combinations of symptoms depending on the species and individual patient. It is diagnosed by the presence of lower urinary tract signs and symptoms in combination with a variety of comorbid health problems, a history of life adversities, and the absence of other conditions that could cause the lower urinary tract signs. IC occurs naturally in humans and cats as a dimensional condition, with patients presenting with mild, moderate, and severe symptoms. Most patients appear to recover without specific treatment. A number of rodent models of IC have been used to study its causes and treatments. Unfortunately, current therapies generally fail to ameliorate IC symptoms long-term. The recent classification of IC as a chronic primary pain disorder calls for a rethinking of current clinical and research approaches to it. Beginning when a patient encounters a clinician, precipitating, perpetuating, and palliating risk factors can be addressed until a cause or reliably effective therapy is identified, and identifying predisposing and preventive factors can inform epidemiological studies and health promotion interventions. Predisposing, precipitating, and perpetuating risk factors, including environmental, psychological, and biological, increase the activity of the central threat response system (CTRS), which plays a clinically important role in IC symptoms. Studies in cats and rodent models have revealed that environmental enrichment (EE), in the absence of bladder-directed therapies, leads to amelioration of IC symptoms, implying a central role for the CTRS in symptom precipitation and perpetuation. Conceptually moving the source of IC pain to the brain as a motivational state rather than one resulting from peripheral nociceptive input offers both clinicians and researchers novel opportunities to improve care for patients with IC and for researchers to use more ecologically valid rodent models. It may even be that IC results from an excess of risk to protective factors, making this imbalance a targetable cause rather than a consequence of IC.","PeriodicalId":12641,"journal":{"name":"Frontiers in Pain Research","volume":" 23","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Pain Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fpain.2024.1405488","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Interstitial cystitis (IC) presents as a chronic pain condition with variable combinations of symptoms depending on the species and individual patient. It is diagnosed by the presence of lower urinary tract signs and symptoms in combination with a variety of comorbid health problems, a history of life adversities, and the absence of other conditions that could cause the lower urinary tract signs. IC occurs naturally in humans and cats as a dimensional condition, with patients presenting with mild, moderate, and severe symptoms. Most patients appear to recover without specific treatment. A number of rodent models of IC have been used to study its causes and treatments. Unfortunately, current therapies generally fail to ameliorate IC symptoms long-term. The recent classification of IC as a chronic primary pain disorder calls for a rethinking of current clinical and research approaches to it. Beginning when a patient encounters a clinician, precipitating, perpetuating, and palliating risk factors can be addressed until a cause or reliably effective therapy is identified, and identifying predisposing and preventive factors can inform epidemiological studies and health promotion interventions. Predisposing, precipitating, and perpetuating risk factors, including environmental, psychological, and biological, increase the activity of the central threat response system (CTRS), which plays a clinically important role in IC symptoms. Studies in cats and rodent models have revealed that environmental enrichment (EE), in the absence of bladder-directed therapies, leads to amelioration of IC symptoms, implying a central role for the CTRS in symptom precipitation and perpetuation. Conceptually moving the source of IC pain to the brain as a motivational state rather than one resulting from peripheral nociceptive input offers both clinicians and researchers novel opportunities to improve care for patients with IC and for researchers to use more ecologically valid rodent models. It may even be that IC results from an excess of risk to protective factors, making this imbalance a targetable cause rather than a consequence of IC.
间质性膀胱炎(IC)是一种慢性疼痛疾病,因病种和患者个体不同而有不同的症状组合。它的诊断依据是下尿路症状和体征的出现,同时伴有各种合并健康问题、生活逆境史,以及不存在可能导致下尿路症状的其他疾病。IC 在人类和猫科动物中自然发生,患者表现为轻度、中度和重度症状。大多数患者似乎无需特殊治疗即可痊愈。许多啮齿类动物模型都被用来研究 IC 的病因和治疗方法。遗憾的是,目前的疗法通常无法长期改善 IC 症状。最近,IC 被归类为慢性原发性疼痛疾病,这就要求我们重新思考当前的临床和研究方法。在找到病因或可靠有效的治疗方法之前,可以从患者与临床医生接触开始,对诱发、延续和缓解风险因素进行处理,而确定易感因素和预防因素可以为流行病学研究和健康促进干预措施提供依据。包括环境、心理和生物在内的易感、诱发和持续风险因素会增加中枢威胁反应系统(CTRS)的活性,而该系统在 IC 症状中发挥着重要的临床作用。对猫和啮齿动物模型的研究表明,在没有膀胱导向疗法的情况下,环境强化(EE)可改善 IC 症状,这意味着中枢威胁反应系统(CTRS)在症状沉淀和持续方面发挥着核心作用。从概念上讲,将 IC 疼痛的源头转移到大脑是一种动机状态,而不是外周痛觉输入所导致的状态,这为临床医生和研究人员提供了新的机会来改善对 IC 患者的护理,也为研究人员提供了使用更多生态学上有效的啮齿类动物模型的机会。IC 甚至可能是风险因素多于保护因素的结果,因此这种不平衡是 IC 的一个目标原因,而不是结果。